allogeneic donor-derived virus -specific T cell therapy (Tehran University)

N/A

Report date: 2025/03/14 16:20:50

Base Information

Drug Nameallogeneic donor-derived virus -specific T cell therapy (Tehran University)
Drug Alias Nameallogeneic CMV specific T-cell therapy (Tehran University)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIran
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTehran University Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesTehran University Of Medical Sciences
Inactive CompaniesN/A
Active IndicationsCytomegalovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A